Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite drug Ivermectin has been found effective for treating the omicron variant of COVID-19 in a Phase III trial.
Ivermectin is an amazing medicine, so amazing in fact that it has been prescribed by doctors to human patients over 4 billion times, and in 2015 a Nobel Prize was awarded to its creators when they found out that Ivermectin in addition to killing parasites also has anti-viral properties. So you would think, in the time of global pandemic with a respiratory virus, something like Ivermectin would be the first place they'd look to use to treat people with. You would think that, but you'd be wrong. Really, really wrong.
"Beloved, I wish above all things that thou mayest prosper and be in health, even as thy soul prospereth." 3 John 1:2 (KJB)
There is no money in Ivermectin, all it does is make people well, it doesn't make you fabulously wealthy like mRNA vaccines do. I have know many people who have taken Ivermectin to treat COVID, and none of them had any side effects at all. With some it worked great, and with others the effect was more moderate, but in all cases it speeded the time in which it took for them to recover. None of those people were hospitalized, which is a huge thing. I keep a bottle of doctor prescribed Ivermectin tablets in my cabinet should the occasion ever arise for me to need them. In the meantime, by taking supplements, eating good and working out, I am 99.2% protected from the COVID virus, and I am 100% protected from vaccine side effects.
Now, for those of you who want to 'follow this science', enjoy this!
Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19
In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infectious diseases since six decades prior, honoured the discovery of ivermectin (IVM), a multifaceted drug deployed against some of the world's most devastating tropical diseases. Since March 2020, when IVM was first used against a new global scourge, COVID-19, more than 20 randomized clinical trials (RCTs) have tracked such inpatient and outpatient treatments. Six of seven meta-analyses of IVM treatment RCTs reporting in 2021 found notable reductions in COVID-19 fatalities, with a mean 31% relative risk of mortality vs. controls. During mass IVM treatments in Peru, excess deaths fell by a mean of 74% over 30 days in its ten states with the most extensive treatments. Reductions in deaths correlated with the extent of IVM distributions in all 25 states with p < 0.002. Sharp reductions in morbidity using IVM were also observed in two animal models, of SARS-CoV-2 and a related betacoronavirus. The indicated biological mechanism of IVM, competitive binding with SARS-CoV-2 spike protein, is likely non-epitope specific, possibly yielding full efficacy against emerging viral mutant strains. READ MORE
UFC COMMENTATOR AND PODCASTER JOE ROGAN TESTS POSITIVE FOR COVID, TAKES IVERMECTIN, MONOCLONAL ANTIBODIES & VITAMINS, RECOVERS IN 3 DAYS
Japan’s Kowa says Ivermectin effective against COVID-19 variant Omicron in phase III trial
FROM ALARABIYA NEWS: The trial found ivermectin has “an antiviral effect” against the variant, Kowa said without providing further details. The firm has been working with Kitasato University, a medical university in Tokyo.
The use of Ivermectin to treat COVID-19 is currently being investigated in a UK trial run by the University of Oxford. The researchers said on Monday that it was still under way and they did not want to comment further until they have results to report.
WELCOME TO YEAR 3 OF 15 DAYS TO FLATTEN THE CURVE
Clinical trials evaluating the drug, which is used to treat parasites in animals and humans, are ongoing but promotion of the drug as a COVID-19 treatment has generated controversy. The drug is not approved for treatment of COVID-19 in Japan and the US Federal Drug Administration has repeatedly warned against its use. READ MORE
No comments:
Post a Comment